Activation Of Memory/Effector T Cells And Association Between Prognosis And Ox40-Positive T Cells In Advanced Head And Neck Cancer Patients Treated With Anti-Programmed Death-1 Antibody

Hirofumi Ohmura,Kyoko Yamaguchi,Fumiyasu Hanamura, Tanoue Kenrou,Shiho Kawagoe,Kohei Arimizu,Yuzo Matsushita,Tatsuhiro Kajitani,Shingo Tamura,Hozumi Shimokawa,Keita Uchino,Hisanobu Oda,Yudai Shinohara,Mamoru Ito,Kenji Tsuchihashi,Taichi Isobe,Hiroshi Ariyama,Hitoshi Kusaba,Koichi Akashi,Eishi Baba

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览22

暂无评分

摘要

35Background: Anti-programmed death-1 (PD-1) monoclonal antibody, nivolumab, enhances anti-tumor activity by inhibiting the interaction of PD-1 and programmed death-1 ligand 1 and has shown efficac...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要